drugset / Trial / NCT07089173

The Effect-site Concentration of Remifentanil Blunting Endotracheal Intubation Responses During Anesthesia Induction With Lidocaine or Sufentanil Combined With Etomidate: A Randomized Controlled Study

NCT07089173

Recruiting 99 enrolled Peking University Shenzhen Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

The aim of this study was to compare the effect-site target concentration (including EC₅₀ and EC₉₀) of remifentanil required to suppress cardiovascular responses to tracheal intubation during anesthesia induction with etomidate combined with either lidocaine or sufentanil.

Timeline

Start
2025-08-01
Primary completion
2026-07-30
Completion
2026-07-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 1.5 mg/kg Intravenous
Subject Sufentanil Other / unclassified 0.2 ug/kg Intravenous

Indications

No indication recorded.